- Home
- SCPH vs IDR Comparison
SCPH vs IDR Comparison
Compare SCPH & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- IDR
- Stock Information
- Founded
- SCPH 2013
- IDR 1996
- Country
- SCPH United States
- IDR United States
- Employees
- SCPH N/A
- IDR N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- SCPH Health Care
- IDR Basic Materials
- Exchange
- SCPH Nasdaq
- IDR Nasdaq
- Market Cap
- SCPH 173.6M
- IDR 154.1M
- IPO Year
- SCPH 2017
- IDR N/A
- Fundamental
- Price
- SCPH $2.78
- IDR $13.43
- Analyst Decision
- SCPH Strong Buy
- IDR Strong Buy
- Analyst Count
- SCPH 3
- IDR 1
- Target Price
- SCPH $14.00
- IDR $14.00
- AVG Volume (30 Days)
- SCPH 637.0K
- IDR 172.4K
- Earning Date
- SCPH 03-19-2025
- IDR 05-05-2025
- Dividend Yield
- SCPH N/A
- IDR N/A
- EPS Growth
- SCPH N/A
- IDR 344.26
- EPS
- SCPH N/A
- IDR 0.52
- Revenue
- SCPH $36,332,000.00
- IDR $21,955,008.00
- Revenue This Year
- SCPH $134.20
- IDR $86.37
- Revenue Next Year
- SCPH $99.40
- IDR $11.11
- P/E Ratio
- SCPH N/A
- IDR $26.03
- Revenue Growth
- SCPH 167.28
- IDR 64.94
- 52 Week Low
- SCPH $2.72
- IDR $7.59
- 52 Week High
- SCPH $5.65
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- SCPH 34.45
- IDR 56.41
- Support Level
- SCPH $2.87
- IDR $13.20
- Resistance Level
- SCPH $3.08
- IDR $14.22
- Average True Range (ATR)
- SCPH 0.18
- IDR 0.74
- MACD
- SCPH -0.00
- IDR 0.16
- Stochastic Oscillator
- SCPH 11.70
- IDR 74.60
Stock Price Comparison Chart: SCPH vs IDR
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.